Clinical Trials Browser

Prostate Cancer Metastatic × Abiraterone Acetate × 90 days × Clear all

NCT06136624 2026-05-05

OMAHA-003

Phase 3 Recruiting

Prostate Cancer Metastatic

NCT02913196 2026-04-20

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Phase 1 Completed

Prostate Cancer Metastatic